Potential pharmacological therapies for atrial fibrillation. A computational study

Potential pharmacological therapies for atrial fibrillation. A computational study

Bibliographic Details
Main Authors:	Sánchez, C, Corrias, A, Laguna, P, Davies, M, Swinton, J, Jacobson, I, Pueyo, E, Rodriguez, B
Format:	Conference item
Published:	IEEE 2010

Similar Items

The Na+/K+ pump is an important modulator of refractoriness and rotor dynamics in human atrial tissue
by: Sánchez, C, et al.
Published: (2012)

Inter−subject variability in human atrial action potential in sinus rhythm versus atrial fibrillation patients
by: Sánchez, C, et al.
Published: (2014)

Atrial fibrillation and bisphosphonate therapy.
by: Pazianas, M, et al.
Published: (2010)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
by: van Walraven, C, et al.
Published: (2009)

Atrial fibrillation dynamics and ionic block effects in six heterogeneous human 3D virtual atria with distinct repolarization dynamics
by: Sánchez, C, et al.
Published: (2017)

In-silico trials with human modelling and simulation for guiding optimal stratification of atrial fibrillation patients to catheter ablation and pharmacological therapy
by: Dasí i Martinez, A
Published: (2023)

Mechanisms of atrial fibrillation
by: Wijesurendra, RS, et al.
Published: (2019)

What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria
by: Dasí, A, et al.
Published: (2023)

Challenges of anticoagulant therapy in patients with atrial fibrillation in clinical practice.
by: Hobbs, R
Published: (2012)

Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses
by: Bedford, J, et al.
Published: (2021)

Stroke prevention in atrial fibrillation
by: Hobbs, F
Published: (2003)

Atrial fibrillation is associated with cardiac hypoxia.
by: Gramley, F, et al.
Published: (2010)

Role of diabetes mellitus in atrial fibrillation and potential new treatments
by: Ziberna, K
Published: (2020)

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
by: Camm, A, et al.
Published: (2010)

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
by: Camm, A, et al.
Published: (2010)

Synaptic plasticity in cardiac innervation and its potential role in atrial fibrillation
by: Ashton, J, et al.
Published: (2018)

In Silico TRials guide optimal stratification of ATrIal FIbrillation patients to Catheter Ablation and pharmacological medicaTION: the i-STRATIFICATION study
by: Dasí, A, et al.
Published: (2024)

The clinical epidemiology of atrial fibrillation in a population cohort and methods to identify those at risk of atrial fibrillation
by: Gardezi, S
Published: (2019)

One hundred years of atrial fibrillation.
by: Aronson, J
Published: (2005)

A mathematical model for atrial fibrillation
by: Berger, Ronald David
Published: (2006)

Atrial fibrillation and the use of oral bisphosphonates.
by: Pazianas, M, et al.
Published: (2011)

Anticoagulant management in patients with atrial fibrillation.
by: Fitzmaurice, D, et al.
Published: (2009)

Should we screen for atrial fibrillation?
by: Lown, M, et al.
Published: (2017)

Treatment pathways for patients with atrial fibrillation.
by: Hodgkinson, J, et al.
Published: (2012)

Strategies in the surgical management of atrial fibrillation
by: Harling, L, et al.
Published: (2011)

Novel computational analysis of left atrial anatomy improves prediction of atrial fibrillation recurrence after ablation
by: Varela, M, et al.
Published: (2017)

Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia
by: Beshir, S.A., et al.
Published: (2016)

Statin therapy may influence the incidence of postoperative atrial fibrillation: what is the evidence?
by: Saso, S, et al.
Published: (2009)

Screening for atrial fibrillation: A call for evidence
by: Jones, N, et al.
Published: (2019)

Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
by: Chan, Kevin E., et al.
Published: (2016)

Molecular Basis of Atrial Nitroso-Redox Imbalance in Permanent Human Atrial Fibrillation
by: Reilly, S, et al.
Published: (2009)

Pharmacologic exposure of an occult atrial septal defect.
by: Mackenzie, I, et al.
Published: (2001)

Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives.
by: Levi, M, et al.
Published: (2009)

Digitalis: a dangerous drug in atrial fibrillation?
by: Testa, L, et al.
Published: (2008)

Atrial fibrillation: a developmental point of view.
by: Mommersteeg, M, et al.
Published: (2009)

Molecular mechanisms underlying the development of Atrial Fibrillation
by: Stefanini, M
Published: (2018)

Measurement of blood pressure in people with atrial fibrillation
by: Clark, CE, et al.
Published: (2019)

Choosing antithrombotics for atrial fibrillation in primary care
by: Mustafa, M, et al.
Published: (2020)

Cerebrovascular disease in dementia: the importance of atrial fibrillation.
by: Ratcliffe, P, et al.
Published: (1985)

Populations of models: A new approach for understanding the mechanisms of atrial fibrillation
by: Liberos, A, et al.
Published: (2016)